GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MedCap AB (OSTO:MCAP) » Definitions » E10

MedCap AB (OSTO:MCAP) E10 : kr5.60 (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is MedCap AB E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

MedCap AB's adjusted earnings per share data for the three months ended in Dec. 2024 was kr2.800. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is kr5.60 for the trailing ten years ended in Dec. 2024.

During the past 12 months, MedCap AB's average E10 Growth Rate was 29.00% per year. During the past 3 years, the average E10 Growth Rate was 35.70% per year. During the past 5 years, the average E10 Growth Rate was 33.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of MedCap AB was 37.80% per year. The lowest was 30.40% per year. And the median was 33.45% per year.

As of today (2025-04-04), MedCap AB's current stock price is kr350.50. MedCap AB's E10 for the quarter that ended in Dec. 2024 was kr5.60. MedCap AB's Shiller PE Ratio of today is 62.59.

During the past 13 years, the highest Shiller PE Ratio of MedCap AB was 148.93. The lowest was 60.83. And the median was 91.07.


MedCap AB E10 Historical Data

The historical data trend for MedCap AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedCap AB E10 Chart

MedCap AB Annual Data
Trend Apr15 Apr16 Apr17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.66 2.24 3.16 4.34 5.60

MedCap AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.34 4.66 4.98 5.28 5.60

Competitive Comparison of MedCap AB's E10

For the Medical Devices subindustry, MedCap AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedCap AB's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MedCap AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where MedCap AB's Shiller PE Ratio falls into.


;
;

MedCap AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MedCap AB's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=2.8/132.9872*132.9872
=2.800

Current CPI (Dec. 2024) = 132.9872.

MedCap AB Quarterly Data

per share eps CPI Adj_EPS
201501 0.037 99.172 0.050
201504 0.486 99.941 0.647
201507 0.200 100.027 0.266
201510 0.500 100.301 0.663
201601 0.100 99.931 0.133
201604 0.632 100.732 0.834
201607 0.100 101.080 0.132
201610 -0.100 101.485 -0.131
201701 -0.200 101.326 -0.262
201704 0.205 102.615 0.266
201707 0.300 103.301 0.386
201710 0.500 103.202 0.644
201803 0.600 103.962 0.768
201806 0.007 104.875 0.009
201809 0.100 105.679 0.126
201812 -0.700 105.912 -0.879
201903 1.200 105.886 1.507
201906 1.000 106.742 1.246
201909 0.800 107.214 0.992
201912 1.000 107.766 1.234
202003 0.700 106.563 0.874
202006 1.300 107.498 1.608
202009 0.800 107.635 0.988
202012 1.300 108.296 1.596
202103 0.900 108.360 1.105
202106 1.100 108.928 1.343
202109 1.800 110.338 2.169
202112 2.700 112.486 3.192
202203 1.300 114.825 1.506
202206 1.400 118.384 1.573
202209 2.500 122.296 2.719
202212 2.700 126.365 2.841
202303 1.700 127.042 1.780
202306 3.200 129.407 3.289
202309 2.600 130.224 2.655
202312 4.200 131.912 4.234
202403 3.800 132.205 3.822
202406 3.800 132.716 3.808
202409 3.500 132.304 3.518
202412 2.800 132.987 2.800

Add all the adjusted EPS together and divide 10 will get our e10.


MedCap AB  (OSTO:MCAP) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

MedCap AB's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=350.50/5.60
=62.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of MedCap AB was 148.93. The lowest was 60.83. And the median was 91.07.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


MedCap AB E10 Related Terms

Thank you for viewing the detailed overview of MedCap AB's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


MedCap AB Business Description

Traded in Other Exchanges
Address
Sundbybergsvagen 1, Solna, SWE, 171 73
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.